3-Amino-4-(4-cyclopropyl-1-naphthyl)-1H-1,2,4-triazole-5(4H)-thione - CAS 878671-96-6
Catalog: |
BB038662 |
Product Name: |
3-Amino-4-(4-cyclopropyl-1-naphthyl)-1H-1,2,4-triazole-5(4H)-thione |
CAS: |
878671-96-6 |
Synonyms: |
3-Amino-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazole-5-thiol; 3-amino-4-(4-cyclopropyl-1-naphthalenyl)-1H-1,2,4-triazole-5-thione; 5-Amino-4-(4-cyclopropyl-1-naphthalenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione; 3H-1,2,4-Triazole-3-thione, 5-amino-4-(4-cyclopropyl-1-naphthalenyl)-2,4-dihydro- |
IUPAC Name: | 3-amino-4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5-thione |
Description: | 3-Amino-4-(4-cyclopropyl-1-naphthyl)-1H-1,2,4-triazole-5(4H)-thione is an intermediate of Lesinurad, a HEK293 cell-based inhibitor. |
Molecular Weight: | 282.36 |
Molecular Formula: | C15H14N4S |
Canonical SMILES: | C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NNC4=S)N |
InChI: | InChI=1S/C15H14N4S/c16-14-17-18-15(20)19(14)13-8-7-10(9-5-6-9)11-3-1-2-4-12(11)13/h1-4,7-9H,5-6H2,(H2,16,17)(H,18,20) |
InChI Key: | VHPOGQZYQNLNNN-UHFFFAOYSA-N |
Boiling Point: | 475.2±38.0°C (Predicted) |
Purity: | >98% |
Density: | 1.52±0.1 g/cm3 (Predicted) |
Storage: | Store at 2-8°C |
LogP: | 3.75000 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P280, P301+P312, P302+P352, P305+P351+P338, P321, P330, P332+P313, P337+P313, P362, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-2020062720-A1 | Novel preparation method for anti-gout drug lesinurad, and key intermediate thereof | 20170517 |
CZ-2016491-A3 | Process for the preparation of 5-amino-4- (1-cyclopropylnaphthalen-4-yl) -4H-1,2,4-triazole-3-thiol, key intermediate for the production of 2- (5-bromo-4- (1-cyclopropylnaphthalene-4) -yl) -4H-1,2,4-triazol-3-ylthio) acetic acid lesinurad | 20160811 |
EP-3281941-A1 | Process for preparing 2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid | 20160811 |
EP-3281941-B1 | Process for preparing 2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid | 20160811 |
US-10183915-B2 | Axially chiral isomers, and preparation methods therefor and pharmaceutical uses thereof | 20150403 |
Complexity: | 445 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 282.09391764 |
Formal Charge: | 0 |
Heavy Atom Count: | 20 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 282.09391764 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 85.7 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Amines and Anilines
Customers Also Viewed
-
[1408282-26-7]
8-Fluoro-4,5-dihydro-1H-azepino[5,4,3-CD]indol-6(3H)-one
-
[63089-56-5]
4-Amino-1,2,3,5,6,7-hexahydro-s-indacene
-
[2093414-16-3]
1,1'-Bis[3-(trimethylammonio)propyl]ferrocene dichloride
-
[86938-64-9]
4,5-Dibromophthalonitrile
-
[80935-59-7]
(Benzene-1,3,5-triyl)triacetonitrile
-
[133407-82-6]
MG-132
INDUSTRY LEADERS TRUST OUR PRODUCTS